Lecanemab is a recombinant humanized immunoglobulin gamma 1 (IgG1) monoclonal antibody directed against aggregated soluble and insoluble forms of amyloid beta (A?), which are implicated in the pathophysiology of Alzheimer’s disease.[L44537] Lecanemab works to…